EverHint Signal — SMA20 × SMA50 Crossover — December 18, 2025

What This Signal Is (Quick)

The SMA20 × SMA50 Crossover strategy identifies fresh momentum shifts by tracking when the 20-day simple moving average (SMA20) crosses the 50-day simple moving average (SMA50).

Signal Types:

• Buy Signal (Golden Cross): SMA20 crosses above SMA50 → short-term momentum (20 days) exceeds medium-term trend (50 days), bullish confirmation for 4-12 week positions
• Sell Signal (Death Cross): SMA20 crosses below SMA50 → short-term momentum weakens below medium-term trend, bearish confirmation

Key Characteristics:

• Uses two SMAs (both simple moving averages) for maximum stability
• Most stable strategy in the EverHint lineup—fewer signals but highest quality (fewer whipsaws)
• Better suited for medium-term trends with confirmed momentum
• Lower risk entries compared to faster EMA-based strategies (EMA10 × EMA30, EMA10 × SMA50)
• Golden/Death Cross terminology widely recognized by institutional traders

Best For: Medium-term trend followers seeking high-quality, low-noise signals. The dual-SMA system produces fewer false signals than EMA crossovers, making it ideal for "set it and forget it" swing trades with 4-12 week holding periods. Confirmation bias is lower—when SMA20 crosses SMA50, the trend shift is typically real, not a head fake.

This is an experimental scanner designed for educational use and back-testing.

How We Ranked Today (Reader Version)

Today's signals are ranked by RSI (14-day Relative Strength Index) to identify the most oversold (for buy signals) and most overbought/weakening (for sell signals) opportunities.

Buy-Side Ranking Logic: Lower RSI = more oversold = higher rank. We prioritize Golden Cross signals when stocks are oversold (RSI <50), not extended (RSI >70). The ideal setup: SMA20 crosses above SMA50 WHILE stock is oversold = mean reversion + momentum confirmation combo.

Sell-Side Ranking Logic: Lower RSI after a Death Cross can indicate bearish momentum accelerating from already weak levels—these are stocks losing momentum and potentially breaking down.

We overlay:

• Insider Net (USD): Net insider buying or selling over last 90 days (Purchases - Sales only, ignoring awards/exercises)
• Days → Earnings: Proximity to next earnings report (affects volatility and signal reliability)
• Market Cap: Liquidity and institutional quality

Critical Context: SMA crossovers are the most reliable trend-following signals. Today's VIX at 16.82 (down -4.5%) suggests normal volatility—ideal conditions for medium-term swing trades. SMA20 × SMA50 produces fewer signals than EMA strategies but higher win rates. In choppy markets (VIX >20), even SMA crossovers can whipsaw, but they're the last to fail. Always check volume and price action for confirmation.

Signals are for educational use and back-testing. Always check broader market context before trading.

📈 Buy-Side Signals (20 Total)

SMA20 crossed above SMA50 on today's close. Golden Cross confirmed—short-term momentum exceeds medium-term trend.

Buy-Side Field Notes:

• RSI Distribution: CWK (35.6) and VSEC (37.7) are deeply oversold—highest bounce probability. OSIS (45.0), AM (48.0), FBIN (49.9), NVR (50.0), STEP (51.8), GDS (52.3), MMS (53.3), ELV (54.5), BEAM (54.2), EQR (54.3), WTS (54.3), CLF (54.8) all below neutral 50 RSI = oversold zone favoring Golden Cross entries. FLEX (58.2), OR (59.0), AROC (60.7), SLAB (61.3), HGV (62.0), PAG (63.3) closer to neutral—less oversold but still have room to run.
• Insider Net: CSX (not in top 20 table but signal #11 at RSI 66.0) had CEO ANGEL STEPHEN F PURCHASE $2,027,850 on 10/20 at $36.87—stock now $36.61, massive insider conviction at current levels. MIDD (not in top 20, RSI 88.6—extremely extended) director Nerbonne Robert A purchased $100,247.78 on 12/9 at $128.52—stock now $148.24 (+15.4% above purchase), insider timing confirmed profitable. AROC director Rebrook Jason C purchased $241,580 on 9/19 at $24.16—stock now $25.20 (+4.3%). MMS had minimal net buying of +$1,499 (Warren Michael J. and RAJAN GAYATHRI small purchases). OSIS had director Hawkins sold -$424,725 and officer Morben sold -$116,105 = -$540,830 net (bearish). AM director Klimley sold -$87,950 (mild bearish). WTS CAO Halloran sold -$167,452 on 12/17 (routine selling). FLEX had multiple insider sales totaling -$2,951,371 (bearish but likely profit-taking). All others: No significant P/S activity.
• Days → Earnings: OSIS and ELV both report in 35 days (soonest in top 20). NVR at 40 days. EQR at 46 days, SLAB at 47 days, FLEX at 48 days. Most have 49-70 days runway (low event risk).
• Sector Concentration: 4 Industrials (VSEC, FBIN, MMS, WTS), 3 Technology (OSIS, GDS, SLAB, FLEX), 2 Real Estate (CWK, EQR), 2 Healthcare (ELV, BEAM), 2 Basic Materials (CLF, OR), 2 Energy (AM, AROC), 2 Consumer Cyclical (NVR, HGV, PAG), 1 Financial Services (STEP). Broad diversification across sectors.
• Not in Top 20 but Notable: CSX (RSI 66.0) at rank 21—CEO's $2M insider buy is THE most bullish signal in entire dataset. MIDD (RSI 88.6) extremely overbought but insider buy profitable (+15%). SSB (RSI 79.1), AMP (RSI 78.6), AIG (RSI 82.5), BEN (RSI 78.5)—all extended but may have momentum continuation. MC (RSI 77.7), EXLS (RSI 76.7), BKNG (RSI 73.3), DXCM (RSI 65.3), SNPS (RSI 69.7), NXPI (RSI 73.5), NOVT (RSI 68.4), ROKU (RSI 73.0)—momentum names with Golden Crosses at elevated RSI levels.

Recent Headlines (Buy-Side Signals):

• CSX (not in top 20, RSI 66.0): CEO ANGEL STEPHEN F made MASSIVE $2,027,850 purchase on 10/20/25 at $36.87—stock now at $36.61, buying AT CURRENT LEVELS. Officer Boone Kevin S. sold shares on 10/22 but CEO's conviction is extreme. Officer Burns Michael S. also sold on 10/20. Net insider flow dominated by CEO's mega-buy. This is a high-conviction insider signal despite not making top 20 due to higher RSI.

• MIDD (not in top 20, RSI 88.6): Director Nerbonne Robert A purchased $100,247.78 on 12/9 at $128.52—stock now $148.24 (+15.4%). Insider timing proved profitable. Stock extremely overbought at RSI 88.6 but Golden Cross + insider buy combo suggests more upside.

• AROC: Zacks article 12/17 "Here is What to Know Beyond Why Archrock, Inc. (AROC) is a Trending Stock"—stock gaining attention. Director Rebrook Jason C purchased $241,580 on 9/19 at $24.16—stock now $25.20 (+4.3%). Insider buy still in the money. Officer Thode Eric W sold $1,022,533 on 11/10 (offsetting).

• ROKU: Morgan Stanley double-upgraded 12/16 from "underweight" to "overweight," price target hiked to $135 from $85—stock surged. Multiple articles 12/16-12/17: "ROKU is Considered a Good Investment by Brokers," "Are You Looking for a Top Momentum Pick?" Cathie Wood's Ark dumped shares 12/17. Massive insider selling by CEO Wood Anthony J. (sold $1.8M+ in Oct-Dec), CFO Jedda Dan (multiple sales), others. Net insider: VERY BEARISH. Golden Cross conflicts with insider selling—caution.

• BKNG: Multiple articles 12/18: "Why Booking, Expedia Are AI's Top Travel Partners"—AI reshaping hotel booking. "Travel Demand Still Rising in 2026? 4 Stocks to Ride the Boom" (Zacks). "Here is What to Know Beyond Why Booking Holdings Inc. (BKNG) is a Trending Stock." Rate cuts and global events setting stage for 2026 travel spending. Minor insider selling by CEO Fogel ($97,415 on 11/17) and director Wittman ($75,450 on 11/17)—routine.

• AIG: Major announcement 12/18: "AIG to Form Special Purpose Vehicle through Strategic Partnership with Amwins and Blackstone, and Launches Collaboration with Palantir on GenAI Capabilities." Forming new Lloyd's Syndicate 2479 with Amwins and Blackstone-backed capital starting 1/1/26. Also: "AIG Becomes Largest Shareholder and Strategic Partner of Salford City FC" in multi-year deal through 2029/2030 season. "AIG Appoints Adam Clifford, Chief Executive Officer, International Commercial Insurance" on 12/16. "AIG Appoints Scott Leney as Regional President, AIG Asia Pacific" on 12/14. Massive strategic moves—bullish.

• BEN (Franklin Resources): Announced 12/17 "Quarterly Dividend and Addition to Stock Repurchase Program"—raised dividend to $0.33/share (+3.1% QoQ), payable 1/9/26. Raised dividend every year since 1981. Insider: officer Gamba Daniel received massive $10,093,007 award on 10/15 (not open-market). Positive catalyst.

• AM (Antero Midstream): Infinity Natural Resources announced 12/17 it "Publishes Updated Hedge Positions" following acquisition of Ohio Utica Shale assets from Antero Resources and Antero Midstream. Stock in play due to M&A. Director Klimley sold -$87,950 on 12/16 (mild bearish).

• ONC (BeOne Medicines): Announced 12/18 "U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma." FDA awards Fast Track for therapies showing potential—positive catalyst BUT stock has Death Cross sell signal (see sell-side section). Massive insider selling by officer Wu Xiaobin ($952,418 total) and officer Lee Chan Henry ($116,200) in Nov. Conflicting signals.

• AMP (Ameriprise Financial): Zacks article 12/18 "Here's Why Ameriprise Financial Services (AMP) is a Strong Growth Stock." Announced 12/11 "Growth Opportunities and Robust Resources Draw Four Advisors Managing Nearly $300 Million in Client Assets to Ameriprise Financial." Columbia Threadneedle Investments launched six new ETFs 12/15 (related to AMP coverage). No recent insider activity.

• NXPI (NXP Semiconductors): Featured in multiple articles 12/18: "Top Semiconductor Stocks for 2026—Nvidia and Broadcom Lead Chip Picks" (Morgan Stanley)—NXPI not top pick but sector coverage positive. "Rep. Gilbert Ray Cisneros, Jr. Buys NXP Semiconductors Stock" on 11/18 ($1,001-$15,000 range). Director Southern Julie (Chair) PURCHASED $50,733 on 12/3 at $225.48—stock now $222.08 (slightly underwater). Officer Jensen sold -$524,791 on 12/3 (net insider: -$474,058, bearish). Golden Cross conflicts with net insider selling.

• OR Royalties: Announced 12/16 "Select Asset Updates and C$43.9 Million of Recent Share Repurchases Under the Normal Course Issuer Bid." Company buying back shares aggressively—bullish signal. Zacks articles 12/16: "OR Royalties (OR) is an Incredible Growth Stock: 3 Reasons Why" and "Wall Street Analysts Think OR Royalties (OR) Could Surge 25.04%." Analyst price target hints 25% upside. No insider activity.

• BEAM (Beam Therapeutics): Announced 12/18 "Beam Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference." CEO John Evans presenting at JPM Healthcare—standard biotech catalyst. No recent insider activity. Clean technical Golden Cross.

• No other tickers had significant news in last 7 days. Golden Crosses are technical signals.

📉 Sell-Side Signals (5 Total)

SMA20 crossed below SMA50 on today's close. Death Cross confirmed—short-term momentum weakening below medium-term trend.

Sell-Side Field Notes:

• RSI Distribution: TECH (23.0) and ONC (23.0) extremely oversold despite Death Cross—paradoxical signals. Could mark capitulation bottoms OR accelerate lower. BWIN (34.3), NVT (35.7) deeply oversold. ERIC (52.7) closer to neutral—most "normal" Death Cross (not already beaten down). These are "falling knives" or capitulation plays—high risk.
• Insider Net: BWIN has CATASTROPHIC insider selling: insider James Morgan Roche sold 180,000 shares across multiple transactions (12/11-12/15) totaling -$3,969,568.10. This is massive red flag—insider dumping before Death Cross. ONC officer Wu Xiaobin sold $674,077 on 11/13 and $278,341 on 11/12 = $952,418 total. Officer Lee Chan Henry sold $116,200 on 11/12. Net: -$952,418 (bearish). TECH, NVT, ERIC: No significant P/S activity in last 90 days. TECH had director awards only (ignore).
• Days → Earnings: ERIC and ELV report soonest in 35 days. TECH at 48 days, NVT at 49 days. BWIN and ONC at 68-70 days (longest runway). Low near-term earnings volatility for most.
• Sector Concentration: 2 Healthcare (TECH, ONC), 1 Technology (ERIC), 1 Financial Services (BWIN), 1 Industrials (NVT).

Recent Headlines (Sell-Side Signals):

• ONC (BeOne Medicines): POSITIVE news conflicts with Death Cross and insider selling. Announced 12/18 "U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma"—FDA approval pathway accelerated (bullish fundamental). BUT: Death Cross confirmed + massive insider selling ($952,418 by officers Wu and Lee in Nov) + article 12/16 "BeOne Medicines Shares Gap Down After Insider Selling" confirms market reacting negatively. Stock gapped down from $319.06 to $307.48 on 12/16. Paradox: good news + bad technicals + bad insider = HIGH RISK. Avoid or wait for capitulation.

• BWIN (Baldwin Insurance Group): Massive insider selling by insider James Morgan Roche: sold 100,000 shares on 12/12 at $24.20 = $2,420,000, sold 60,000 shares on 12/11 at $23.34 = $1,400,400, sold 6,023 shares on 12/15 at $24.70 = $148,768. Total: -$3,969,568 in ONE WEEK (12/11-12/15). This is not routine selling—this is panic selling or extreme bearish conviction. Articles 12/16: "Baldwin Insurance Group Insider James Morgan Roche Sells 80,000 Shares" and "Sells 60,000 Shares." Death Cross + insider dump = AVOID. High risk of further downside.

• NVT (nVent Electric): Announced 12/15 "nVent Increases Quarterly Dividend" to $0.21/share (Q1 2026), up 5% from $0.20—bullish dividend raise. Payable 2/6/26 to holders of record 1/23/26. BUT: Death Cross contradicts dividend positive. Officer Wacker Randolph A. (SVP & CAO) had tax withholding (F-InKind) of $329,687 on 10/15—not open-market sale. Mixed signals: dividend up (bullish) vs Death Cross (bearish). Stock broke down technically despite fundamental strength.

• TECH (Bio-Techne): Announced 12/11 "Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology"—strategic partnership (positive). Multiple institutional holding changes in articles 12/12-12/13. Directors received awards on 10/30 (not open-market). Death Cross at RSI 23.0 = extreme oversold. Could be capitulation bottom or continued decline. Biotech sector weakness notable.

• ERIC (Ericsson): No recent news in last 7 days. Death Cross appears purely technical. RSI 52.7 = neutral, not oversold—most "normal" looking Death Cross. Stock crossed below SMA50 from relatively healthy RSI level, not from oversold bounce failure. Cleanest short candidate on sell-side.

• No other sell-side tickers had significant news.

Field Notes (Strategy-Specific)

SMA20 × SMA50 Crossover Interpretation:

• Golden Cross (Buy): SMA20 crosses above SMA50 = short-term price momentum (20 days) exceeds medium-term trend (50 days). Most reliable bullish signal in technical analysis—widely followed by institutions. Best when combined with RSI <50 (oversold) and increasing volume. SMA crossovers lag price (vs EMA), so signals appear AFTER trend already started, but confirmation quality is higher (fewer whipsaws).
• Death Cross (Sell): SMA20 crosses below SMA50 = short-term momentum fading. Most reliable bearish signal. Institutions often exit on Death Cross confirmation. Today's sell signals have unusually low RSI (TECH 23.0, ONC 23.0, BWIN 34.3, NVT 35.7)—these are "falling knives" that crossed WHILE already oversold = extremely bearish OR capitulation bottoms. ERIC at RSI 52.7 is the only "normal" Death Cross (crossed from healthy level).

RSI Context:

• Buy-side: CWK (35.6) and VSEC (37.7) deeply oversold—highest bounce probability. Mid-range oversold (OSIS 45.0 to WTS 54.3) = ideal Golden Cross zone. Higher RSI (FLEX 58.2 to PAG 63.3) = less oversold but momentum confirmed. Not in top 20: CSX (66.0), DXCM (65.3), NOVT (68.4), SNPS (69.7), ROKU (73.0), BKNG (73.3), NXPI (73.5), MC (77.7), BEN (78.5), AMP (78.6), SSB (79.1), AIG (82.5), MIDD (88.6)—all extended but Golden Cross may propel higher (momentum continuation).
• Sell-side: TECH (23.0), ONC (23.0) = extreme oversold + Death Cross = falling knives. BWIN (34.3), NVT (35.7) = oversold. ERIC (52.7) = neutral, cleanest short. Paradox: oversold + Death Cross = HIGH RISK (either capitulation bounce or accelerated decline).

Sector Rotation:

• Buy-side: 4 Industrials (VSEC, FBIN, MMS, WTS), 4 Technology (OSIS, GDS, SLAB, FLEX), 2 Real Estate (CWK, EQR), 2 Healthcare (ELV, BEAM), 2 Basic Materials (CLF, OR), 2 Energy (AM, AROC), 3 Consumer Cyclical (NVR, HGV, PAG), 1 Financial Services (STEP). Diversified—no single sector dominating. Industrials slightly overweight.
• Sell-side: 2 Healthcare (TECH, ONC), 1 Technology (ERIC), 1 Financial Services (BWIN), 1 Industrials (NVT). Healthcare weakness notable (2 of 5 sell signals).

Insider Activity Summary:

• Most Bullish: CSX CEO's $2,027,850 purchase (not in top 20 but rank 21)—extreme conviction. MIDD director's $100,248 purchase profitable (+15%). AROC director's $241,580 purchase (+4.3%).
• Most Bearish: BWIN insider's -$3,969,568 dump in one week (catastrophic). ONC officers' -$952,418 selling. FLEX officers' -$2,951,371 selling. OSIS director's -$540,830 selling. NXPI net -$474,058 (director buy offset by officer sales).
• Neutral/No Activity: Most tickers have no significant P/S activity (awards/exercises ignored).

Vlad's Take (EverHint)

Market Backdrop: S&P 500 essentially flat at -0.05% to 6,775, Dow down -0.3% to 47,952, Nasdaq barely negative at -0.02% to 23,006. Very choppy, indecisive session with no clear trend—Europe showed strength (DAX +1.05%, FTSE +0.65%, CAC +0.78%) but U.S. failed to follow through. VIX dropped -4.5% to 16.82 = normal volatility (favorable for swing trades). Small-caps (Russell 2000) down -0.39% to 2,508 suggests defensive positioning. Treasury yields eased slightly (10Y at 4.12%, down 1bp). Crypto mixed: Bitcoin -1.03% to $85,318, Ethereum -0.61% to $2,815. Overall: Neutral/choppy environment with low conviction—not ideal for aggressive trades but manageable for quality signals.

SMA20 × SMA50 crossovers are designed for exactly this environment. Unlike faster EMA systems that whipsaw in choppy markets, SMA crossovers wait for confirmed trend shifts. The 35 Golden Cross signals today (20 in top table) suggest underlying sector rotation happening beneath the surface—even as major indices stay flat, individual stocks are breaking out. The 5 Death Cross signals are cleanup from previous rallies.

The CSX Insider Story (Rank 21, Not in Top 20): CSX Corporation had a Golden Cross today at RSI 66.0 (just outside top 20 due to higher RSI), but the insider activity is TOO IMPORTANT to ignore. CEO STEPHEN F ANGEL made a $2,027,850 PURCHASE on 10/20/25 at $36.87 per share—stock now trading at $36.61. This is a MASSIVE insider buy at essentially CURRENT LEVELS. For context: 55,000 shares purchased. This is not a token buy—this is CEO betting big on the company. Two officers (Boone and Burns) sold shares around same time, but CEO's conviction overwhelms their routine selling. CSX is a railroad (industrials), benefiting from infrastructure spending and supply chain normalization. Golden Cross + $2M CEO buy = high-conviction setup despite extended RSI 66.0. If you believe insiders know more than the market, CSX belongs in your portfolio.

The MIDD Outlier (Rank 33, RSI 88.6): Middleby Corporation at RSI 88.6 is EXTREMELY overbought—normally a red flag. But director Nerbonne Robert A purchased $100,247.78 on 12/9 at $128.52—stock now $148.24 (+15.4% in 9 days). Insider timing proved PERFECT. Stock is commercial foodservice equipment (benefits from restaurant recovery). Golden Cross + profitable insider buy + RSI 88.6 = paradox. High RSI says "overbought, sell," but Golden Cross + insider buy says "momentum continuation." This is a rare case where overbought doesn't mean stop—it means acceleration phase. Risky but high-conviction for momentum traders.

The BWIN Disaster: Baldwin Insurance Group has a Death Cross at RSI 34.3 (oversold) BUT insider James Morgan Roche DUMPED -$3,969,568 in ONE WEEK (12/11-12/15). Sold 180,000 shares across three transactions at $23.34-$24.70. This is not routine selling—this is panic or extreme bearish conviction. Death Cross confirmed 12/18 AFTER insider already bailed. This is a textbook "insiders know first, technicals confirm later" setup. AVOID BWIN. High probability of further downside. Insurance sector typically stable—something is very wrong here.

The ONC Paradox: BeOne Medicines got FDA Fast Track Designation on 12/18 (bullish news) BUT has Death Cross at RSI 23.0 (extremely oversold) + massive insider selling (-$952,418 by officers Wu and Lee in Nov). Stock gapped down 12/16 after insider selling disclosed. Paradox: good fundamental news (FDA) vs bad technicals (Death Cross) vs bad insider (selling). Market doesn't care about FDA news—technicals and insiders trump. Biotech is binary: either capitulation bottom here OR further decline to $250-280 zone. Only trade if you're a contrarian betting on oversold bounce. Not for trend followers.

Buy-Side Best Setups (Top 20):

1. CWK (RSI 35.6) - Real estate services, most oversold. Golden Cross from deeply oversold level = highest bounce probability. 63 days to earnings = low event risk.
2. VSEC (RSI 37.7) - Defense/government contractor (VSE Corp). Deeply oversold + Golden Cross. Industrials sector showing relative strength. 69 days to earnings.
3. OSIS (RSI 45.0) - Security equipment, TSA contracts. Mid-range oversold. Reports in 35 days (near-term catalyst). Insider sold -$540,830 (caution).
4. AM (RSI 48.0) - Midstream energy (Antero Midstream). M&A overhang from Infinity Natural Resources acquisition. Director sold -$87,950 (mild bearish). Low-risk entry near neutral RSI.
5. FBIN (RSI 49.9) - Fortune Brands, home/security products. Neutral RSI + Golden Cross = clean setup. 49 days to earnings.
6. NVR (RSI 50.0) - Luxury homebuilder, $7,565/share (high-priced stock). Neutral RSI, 40 days to earnings (near-term). Housing sector strength.
7. STEP (RSI 51.8) - Private equity/asset management (StepStone Group). Financial services strength. 49 days to earnings.
8. GDS (RSI 52.3) - China data center operator. Golden Cross at neutral RSI. 91 days to earnings (longest runway in top 20).
9. MMS (RSI 53.3) - Maximus, government services. Minimal insider buying (+$1,499). Clean setup. 49 days to earnings.
10. ELV (RSI 54.5) - Elevance Health (formerly Anthem). Healthcare managed care. Reports in 35 days. Large cap quality name.

Other Top Buy Setups (Not in Top 20 but High Conviction):

• CSX (RSI 66.0, rank 21) - CEO's $2M buy AT CURRENT LEVELS. Railroad/industrials. Higher RSI but insider conviction overwhelming.
• MIDD (RSI 88.6, rank 33) - Extremely overbought BUT director's buy profitable (+15% in 9 days). Momentum continuation play.
• AIG (RSI 82.5, rank 29) - Major strategic announcements (Blackstone partnership, Lloyd's syndicate, Palantir GenAI collab). Momentum despite extended RSI.
• BEN (RSI 78.5, rank 24) - Franklin Resources raised dividend +3.1%, 44th consecutive year. Dividend growth + Golden Cross.
• ROKU (RSI 73.0, rank 27) - Morgan Stanley double-upgrade to "overweight," PT $135 (from $85). BUT massive insider selling (CEO, CFO). Conflicting signals—trade momentum vs trust insiders.

Sell-Side: Avoid or Counter-Trend Only:

• ERIC (RSI 52.7) - ONLY clean short candidate. Death Cross from neutral RSI (not oversold bounce failure). Telecom equipment weakness. If you short, this is the one.
• TECH (RSI 23.0) - Extreme oversold + Death Cross = falling knife OR capitulation. Biotech sector weak. Only trade if contrarian betting on bounce. NOT a short (too oversold).
• ONC (RSI 23.0) - FDA Fast Track (bullish fundamental) conflicts with Death Cross + insider selling (bearish). Paradox = AVOID. Too many conflicting signals.
• BWIN (RSI 34.3) - Catastrophic insider selling (-$3.97M in one week). Death Cross confirmed. AVOID or short if you believe insider panic justified. High risk of further decline.
• NVT (RSI 35.7) - Raised dividend +5% (bullish) but Death Cross (bearish). Mixed signals. Industrials name (nVent Electric). Wait for clarity—either dividend buyers step in (bounce) or technical breakdown continues (lower). Don't trade yet.

Trading Tips (SMA Crossovers):

• Golden Cross entries: Don't chase immediately. Wait 1-2 days for pullback to SMA20 level for optimal entry. For CWK: entry at $15.80-15.85 (near SMA20 at $15.79). For VSEC: entry at $170-171 (near SMA20 at $170.77). SMA crossovers often pull back to test the crossover level before continuing—this is your entry.
• Stops: Place stops below SMA50 level. For CWK: stop at $15.60 (below SMA50 at $15.78). For VSEC: stop at $170 (below SMA50 at $170.66). Golden Crosses that fail quickly are false signals—exit immediately.
• Targets: SMA crossovers are TREND signals, not quick scalps. Target 8-15% gains over 4-12 weeks. For CWK: target $17.50-18.00 (+10-13%). For VSEC: target $185-190 (+10-13%). Hold until Death Cross or RSI >75.
• Time stops: If Golden Cross doesn't produce 5%+ gain within 4 weeks, reassess. SMA signals are slower but should show progress within a month. If stalled, market may not be respecting the signal—exit.
• Death Cross shorts: Only short ERIC (RSI 52.7, not oversold). TECH/ONC/BWIN/NVT all too oversold to short safely—risk of violent short squeeze. Wait for bounce to RSI 40-45, THEN short if Death Cross still intact.

Risk Warning: Choppy markets (like today—S&P flat, Dow/Nasdaq flat) can produce whipsaws even for stable SMA crossovers. However, SMA20 × SMA50 is the LEAST likely to whipsaw compared to EMA strategies. The low VIX (16.82) is favorable—low volatility means trends are more likely to persist. If VIX spikes above 20 tomorrow, tighten stops. The 35 Golden Cross signals today suggest sector rotation is real—even as indices chop, individual stocks are moving. Focus on highest-quality setups (CSX, CWK, VSEC, MIDD) with insider confirmation or extreme oversold RSI.

Best Setups Ranked (All Signals Considered):

1. CSX (rank 21, RSI 66.0) - CEO's $2M buy trumps higher RSI. Railroad strength.
2. CWK (rank 1, RSI 35.6) - Most oversold Golden Cross. Real estate services.
3. VSEC (rank 2, RSI 37.7) - Defense contractor, deeply oversold + Golden Cross.
4. MIDD (rank 33, RSI 88.6) - Overbought BUT insider buy profitable. Momentum continuation.
5. AIG (rank 29, RSI 82.5) - Multiple strategic announcements. Momentum despite extension.
6. AROC (rank 17, RSI 60.7) - Midstream energy + director insider buy (+$241,580).
7. OSIS (rank 3, RSI 45.0) - Security equipment, earnings in 35 days. Caution: insider sold.
8. BEN (rank 24, RSI 78.5) - Franklin Resources dividend raise. Income + momentum.
9. AM (rank 4, RSI 48.0) - Midstream energy, M&A catalyst. Clean RSI.
10. FBIN (rank 5, RSI 49.9) - Fortune Brands, home products. Neutral RSI clean setup.

If I had to pick 2-3 for tomorrow: CSX (insider conviction), CWK (most oversold), MIDD (momentum + profitable insider buy). For contrarians: TECH or ONC (oversold bounce play, NOT trend trade).

Avoid: BWIN (insider dump), ROKU (conflicting signals—Morgan Stanley upgrade vs insider selling).

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

📈 If this gave you insight, a quick like, share, or subscribe supports the continued work behind EverHint.